Analysis of the GEPIA platform demonstrates that both BRCA1 (Figure 2F) and BRCA2 (Figure 2G) mRNA are overexpressed in serous ovarian cancer, but this overexpression is not statistically significant. The gene discussed is BRCA2; the disease is ovarian serous adenocarcinoma.